A national cancer consortium here has been admitted into an international expert network that will allow it to participate in global cancer trials.
For Singaporeans, it could mean access to new cancer drugs being tested, while the network will gain access to a diverse pool of Asian trial participants.
The immunotherapy Centres Of Research Excellence (imCore) network is a global alliance of scientific and clinical experts in cancer immunotherapy, led by Swiss healthcare company Roche and its subsidiary, biotechnology firm Genentech.
On July 24, the Singapore Translational Cancer Consortium (STCC) became its 27th member, joining groups such as Johns Hopkins Medicine in the United States, the Asan Medical Centre in South Korea and Germany’s University Hospital Essen.
“Singaporean patients will have access to the very latest types of pharmaceuticals that we’re developing,” said Dr Ira Mellman, vice-president of cancer immunology at Genentech, which is based in the US.
ImCore was launched in 2016, with Roche investing more than $150 million in cancer immunotherapy research at the time.
Among its contributions is helping to fund the development of a pancreatic cancer vaccine candidate that is currently in a Phase II trial.
Esta historia es de la edición July 25, 2024 de The Straits Times.
Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.
Ya eres suscriptor ? Conectar
Esta historia es de la edición July 25, 2024 de The Straits Times.
Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.
Ya eres suscriptor? Conectar
Under-16s need more exposure, says fraternity
There are valuable lessons to be learnt from the Singapore Under-16 football team's defeats at the recent Lion City Cup (LCC), said the community on Oct 8.
Kane given 'all-clear' for Nations League games
LONDON – Captain Harry Kane has been given the green light to remain with England for their upcoming Nations League fixtures on Oct 7, after the striker was examined by Football Association (FA) medical staff.
Historic Ohtani 50-50 ball remains in play as auction continues
LOS ANGELES – The owner of the ball that Shohei Ohtani hit for his historic 50th homer of 2024 remains in dispute, but the souvenir will continue to be auctioned off while legal proceedings continue.
DJOKOVIC STORMS PAST COBOLLI
Serb eases into Shanghai Masters last 16 after days of schedule disruption due to rain
France Rugby plans to impose strict discipline
PARIS - French Rugby Federation (FFR) president Florian Grill announced on Oct 7 an overhaul of the system of discipline in the France teams after a summer tour of Argentina was overshadowed by claims of attempted rape and racism.
CHAMPS GALORE AT SWIM WORLD CUP IN S'PORE
Star-studded cast includes Marchand, Pan, le Clos, McKeown, Zhang and Douglass
BOY XANDER LOOKING FRESH FOR THE TASK
Two-time Kranji winner returns after 29 months out, goes well in training on Oct 8
Turn down the K-pop and pay attention to K-healing
The rise of South Korean books about burnout has taken the world by storm.
How is it that Netanyahu is able to keep defying Biden?
The 'tail wagging the dog' situation is not simply about the power of the 'Israel Lobby'. Other factors in the patron-client relationship are in play too.
Most Asean fund managers avoiding new economy firms
Uncertainty over future returns, growth prospects among factors